FDA issues latest guidance to stop ‘gaming’ of system

Scott Gottlieb, commissioner of the Food and Drug Administration (FDA), yesterday announced another set of guidelines aimed at facilitating the entry of generic drugs to the market and preventing “gaming” of the approval system.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

FDA chief Gottlieb resigns after nearly two years

6 March 2019 Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.

Americas

FDA issues guidance on generic versions of complex drugs

11 October 2018 The US Food and Drug Administration has released guidance intended to advance the development of generic versions of complex medical drugs.

Americas

FDA reveals further steps to encourage generic competition

3 January 2018 The US Food and Drug Administration revealed additional steps aimed at encouraging generic competition today.

More on this story

Americas

FDA chief Gottlieb resigns after nearly two years

6 March 2019 Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.

Americas

FDA issues guidance on generic versions of complex drugs

11 October 2018 The US Food and Drug Administration has released guidance intended to advance the development of generic versions of complex medical drugs.

Americas

FDA reveals further steps to encourage generic competition

3 January 2018 The US Food and Drug Administration revealed additional steps aimed at encouraging generic competition today.

More on this story

Americas

FDA chief Gottlieb resigns after nearly two years

6 March 2019 Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.

Americas

FDA issues guidance on generic versions of complex drugs

11 October 2018 The US Food and Drug Administration has released guidance intended to advance the development of generic versions of complex medical drugs.

Americas

FDA reveals further steps to encourage generic competition

3 January 2018 The US Food and Drug Administration revealed additional steps aimed at encouraging generic competition today.